Du Y, Deng Y, Zhan Y, Yang R, Ren J, Wang W
Biosaf Health. 2025; 5(5):300-307.
PMID: 40078908
PMC: 11894981.
DOI: 10.1016/j.bsheal.2023.06.003.
Naveed A, Eertink L, Wang D, Li F
Viruses. 2024; 16(5).
PMID: 38793662
PMC: 11125849.
DOI: 10.3390/v16050781.
Fan Y, Chen J, Chen Y, Ke Y, Chang G, Chiou S
J Virol. 2024; 98(4):e0177323.
PMID: 38530012
PMC: 11019926.
DOI: 10.1128/jvi.01773-23.
Mertinkova P, Mochnacova E, Bhide K, Kulkarni A, Tkacova Z, Hruskovicova J
Sci Rep. 2021; 11(1):20131.
PMID: 34635758
PMC: 8505397.
DOI: 10.1038/s41598-021-99696-w.
Baykov I, Desyukevich P, Mikhaylova E, Kurchenko O, Tikunova N
Viruses. 2021; 13(8).
PMID: 34452359
PMC: 8402911.
DOI: 10.3390/v13081494.
Post-Vaccination Yellow Fever Antiserum Reduces Zika Virus in Embryoid Bodies When Placental Cells are Present.
Schultz E, Jones T, Hopkins H, Zeng J, Barr K
Vaccines (Basel). 2020; 8(4).
PMID: 33322247
PMC: 7768546.
DOI: 10.3390/vaccines8040752.
MAVS regulates the quality of the antibody response to West-Nile Virus.
OKetch M, Williams S, Larson C, Uhrlaub J, Wong R, Hall B
PLoS Pathog. 2020; 16(10):e1009009.
PMID: 33104760
PMC: 7644103.
DOI: 10.1371/journal.ppat.1009009.
Neuroinvasive West Nile Infection with an Unusual Clinical Presentation: A Single-Center Case Series.
Castaldo N, Graziano E, Peghin M, Gallo T, DAgaro P, Sartor A
Trop Med Infect Dis. 2020; 5(3).
PMID: 32878269
PMC: 7558676.
DOI: 10.3390/tropicalmed5030138.
Antigenic Characterization of New Lineage II Insect-Specific Flaviviruses in Australian Mosquitoes and Identification of Host Restriction Factors.
Harrison J, Hobson-Peters J, Colmant A, Koh J, Newton N, Warrilow D
mSphere. 2020; 5(3).
PMID: 32554715
PMC: 7300350.
DOI: 10.1128/mSphere.00095-20.
A Monoclonal Antibody Specific for Japanese Encephalitis Virus with High Neutralizing Capability for Inclusion as a Positive Control in Diagnostic Neutralization Tests.
Calvert A, Bennett S, Dixon K, Blair C, Roehrig J
Am J Trop Med Hyg. 2019; 101(1):233-236.
PMID: 31115302
PMC: 6609188.
DOI: 10.4269/ajtmh.19-0073.
Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common....
Azami N, Moi M, Ami Y, Suzaki Y, Lim C, Taniguchi S
Virol J. 2018; 15(1):51.
PMID: 29587780
PMC: 5870686.
DOI: 10.1186/s12985-018-0967-x.
Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections.
Zhang X, Jia R, Shen H, Wang M, Yin Z, Cheng A
Viruses. 2017; 9(11).
PMID: 29137162
PMC: 5707545.
DOI: 10.3390/v9110338.
A synthetic peptide derived from domain III envelope glycoprotein of Dengue virus induces neutralizing antibody.
Mary J, Jittmittraphap A, Chattanadee S, Leaungwutiwong P, Shenbagarathai R
Virus Genes. 2017; 54(1):25-32.
PMID: 28948470
DOI: 10.1007/s11262-017-1508-1.
DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
Slon Campos J, Poggianella M, Marchese S, Mossenta M, Rana J, Arnoldi F
PLoS One. 2017; 12(7):e0181734.
PMID: 28742857
PMC: 5526558.
DOI: 10.1371/journal.pone.0181734.
Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry.
Wang J, Yang J, Ge J, Hua R, Liu R, Li X
Virol J. 2016; 13:109.
PMID: 27342050
PMC: 4920995.
DOI: 10.1186/s12985-016-0568-5.
Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.
Adungo F, Yu F, Kamau D, Inoue S, Hayasaka D, Posadas-Herrera G
Clin Vaccine Immunol. 2016; 23(8):689-97.
PMID: 27307452
PMC: 4979174.
DOI: 10.1128/CVI.00209-16.
Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
Chaintoutis S, Diakakis N, Papanastassopoulou M, Banos G, Dovas C
Clin Vaccine Immunol. 2015; 22(9):1040-9.
PMID: 26178384
PMC: 4550672.
DOI: 10.1128/CVI.00302-15.
Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host.
Kuhn R, Dowd K, Post C, Pierson T
Virology. 2015; 479-480:508-17.
PMID: 25835729
PMC: 4900690.
DOI: 10.1016/j.virol.2015.03.025.
Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.
Tinker J, Yan J, Knippel R, Panayiotou P, Cornell K
Toxins (Basel). 2014; 6(4):1397-418.
PMID: 24759174
PMC: 4014742.
DOI: 10.3390/toxins6041397.
B cell response and mechanisms of antibody protection to West Nile virus.
Austin S, Dowd K
Viruses. 2014; 6(3):1015-36.
PMID: 24594676
PMC: 3970136.
DOI: 10.3390/v6031015.